Ranbaxy's Provigil gets tentative FDA approval

By siliconindia staff writer   |   Friday, 20 February 2004, 08:00 Hrs
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories has got tentative approval for Modafinil tablets, a generic form of nacrolepsy drug Provigil, the US Food and Drug Administration (FDA) said late on Thursday.

Provigil, the flagship drug of Cephalon Inc, is prescribed for a rare disorder marked by uncontrollable sleep during normal waking hours.

No other details were immediately available.




SPOTLIGHT
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..